These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 7685654)
1. Comparison of the murine humoral immune response to recombinant simian virus 40 large tumor antigen: epitope specificity and idiotype expression. Bright RK; Shearer MH; Kennedy RC Cancer Immunol Immunother; 1993 Jul; 37(1):31-9. PubMed ID: 7685654 [TBL] [Abstract][Full Text] [Related]
2. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype. Shearer MH; Bright RK; Kennedy RC Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794 [TBL] [Abstract][Full Text] [Related]
3. Idiotype network components are involved in the murine immune response to simian virus 40 large tumor antigen. Mernaugh RL; Shearer MH; Bright RK; Lanford RE; Kennedy RC Cancer Immunol Immunother; 1992; 35(2):113-8. PubMed ID: 1596936 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal anti-idiotypic antibodies induce humoral immune responses specific for simian virus 40 large tumor antigen in mice. Shearer MH; Lanford RL; Kennedy RC J Immunol; 1990 Aug; 145(3):932-9. PubMed ID: 1695650 [TBL] [Abstract][Full Text] [Related]
5. Fine specificity of the murine immune response to SV40 large tumour antigen utilizing synthetic peptides that define selected epitopes. Bright RK; Shearer MH; Kennedy RC Clin Exp Immunol; 1994 Jun; 96(3):491-9. PubMed ID: 7516272 [TBL] [Abstract][Full Text] [Related]
7. Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells. Shearer MH; Bright RK; Lanford RE; Kennedy RC Clin Exp Immunol; 1993 Feb; 91(2):266-71. PubMed ID: 7679059 [TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of immunoglobulin variable regions from murine monoclonal antibodies specific for simian virus 40 large tumour antigen. Shearer MH; Bright RK; Kennedy RC Scand J Immunol; 1994 Oct; 40(4):415-22. PubMed ID: 7939414 [TBL] [Abstract][Full Text] [Related]
9. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity. Bright RK; Shearer MH; Kennedy RC J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411 [TBL] [Abstract][Full Text] [Related]
10. Nucleic acid vaccination against virally induced tumors. Bright RK; Shearer MH; Kennedy RC Ann N Y Acad Sci; 1995 Nov; 772():241-51. PubMed ID: 8546399 [TBL] [Abstract][Full Text] [Related]
11. Comparison of simian virus 40 large T antigen recombinant protein and DNA immunization in the induction of protective immunity from experimental pulmonary metastasis. Watts AM; Shearer MH; Pass HI; Bright RK; Kennedy RC Cancer Immunol Immunother; 1999 Feb; 47(6):343-51. PubMed ID: 10203065 [TBL] [Abstract][Full Text] [Related]
12. Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies. Kennedy RC; Dreesman GR; Butel JS; Lanford RE J Exp Med; 1985 Jun; 161(6):1432-49. PubMed ID: 2409201 [TBL] [Abstract][Full Text] [Related]
13. Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes. Mylin LM; Schell TD; Roberts D; Epler M; Boesteanu A; Collins EJ; Frelinger JA; Joyce S; Tevethia SS J Virol; 2000 Aug; 74(15):6922-34. PubMed ID: 10888631 [TBL] [Abstract][Full Text] [Related]
14. Monospecific polyclonal anti-anti-idiotypic antibodies to the carboxyterminal undecapeptide of the SV40 large tumour antigen. Agostini HT; Gerstenecker B; Haessler C; Braun DG; Brandner G; Hess RD Scand J Immunol; 1995 Mar; 41(3):256-62. PubMed ID: 7532873 [TBL] [Abstract][Full Text] [Related]
15. In vitro selection of SV40 T antigen epitope loss variants by site-specific cytotoxic T lymphocyte clones. Tanaka Y; Tevethia SS J Immunol; 1988 Jun; 140(12):4348-54. PubMed ID: 2453578 [TBL] [Abstract][Full Text] [Related]
16. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection. Newmaster RS; Mylin LM; Fu TM; Tevethia SS Virology; 1998 May; 244(2):427-41. PubMed ID: 9601511 [TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of SV40 induced tumours in mice: a model for vaccine development. Bright RK; Shearer MH; Pass HI; Kennedy RC Dev Biol Stand; 1998; 94():341-53. PubMed ID: 9776255 [TBL] [Abstract][Full Text] [Related]
18. Immunization with soluble simian virus 40 large T antigen induces a specific response of CD3+ CD4- CD8+ cytotoxic T lymphocytes in mice. Schirmbeck R; Zerrahn J; Kuhröber A; Kury E; Deppert W; Reimann J Eur J Immunol; 1992 Mar; 22(3):759-66. PubMed ID: 1312473 [TBL] [Abstract][Full Text] [Related]
19. Effect of point mutations in the native simian virus 40 tumor antigen, and in synthetic peptides corresponding to the H-2Db-restricted epitopes, on antigen presentation and recognition by cytotoxic T lymphocyte clones. Deckhut AM; Tevethia SS J Immunol; 1992 May; 148(10):3012-20. PubMed ID: 1374447 [TBL] [Abstract][Full Text] [Related]
20. Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen. Mylin LM; Bonneau RH; Lippolis JD; Tevethia SS J Virol; 1995 Nov; 69(11):6665-77. PubMed ID: 7474076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]